FDA to Decide 'Quickly' on Pfizer Request to Approve COVID-19 Vaccine for Children 12 to 15
MONDAY, April 12, 2021 -- The Pfizer request to expand emergency use authorization of its COVID-19 vaccine to include children ages 12 to 15 years will be evaluated "as quickly as possible," the U.S. Food and Drug Administration says.
"While the FDA cannot predict how long our evaluation of the data and information will take, we will review the request as expeditiously as possible using our thorough and science-based approach," FDA Acting Commissioner Janet Woodcock said on Twitter, CNN reported.
Currently, the FDA allows the Pfizer vaccine to be given to people aged 16 years and older. Pfizer submitted a request to expand eligibility on Friday, and the company said it would seek similar approvals in other nations in the coming days.
The other two COVID-19 vaccines being used in the United States -- from Moderna and Johnson & Johnson -- are authorized for emergency use in people 18 years and older.
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Further Support and Information on COVID-19
Read this next
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of May 3 to 7, 2021. This roundup...
FRIDAY, May 7, 2021 -- As U.S. health officials prepare to authorize the Pfizer COVID-19 vaccine for emergency use in younger children, a new poll shows that less than a third of...
FRIDAY, May 7, 2021 -- It is likely that the United States will achieve President Joe Biden's target of having at least one dose of a COVID-19 vaccine into the arms of 70 percent...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.